The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Hanauer, Stephen
Item TypeName
Concept Tumor Necrosis Factor-alpha
Concept Receptors, Tumor Necrosis Factor
Academic Article A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
Academic Article Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.
Academic Article An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial.
Academic Article Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial.
Academic Article Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.
Academic Article Immunogenicity of infliximab in Crohn's disease.
Academic Article Crohn's disease: step up or top down therapy.
Academic Article An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease.
Academic Article Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: overview of randomized clinical studies.
Academic Article Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.
Academic Article Clinical perspectives in Crohn's disease. Turning traditional treatment strategies on their heads: current evidence for "step-up" versus "top-down".
Academic Article Refining the role of TNF antagonists for Crohn's disease. Introduction.
Academic Article Risks and benefits of the use of concomitant immunosuppressives and biologics in inflammatory bowel disease.
Academic Article Selecting appropriate anti-TNF agents in inflammatory bowel disease.
Academic Article Top-down versus step-up approaches to chronic inflammatory bowel disease: presumed innocent or presumed guilty.
Academic Article General principles and pharmacology of biologics in inflammatory bowel disease.
Academic Article African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity.
Academic Article Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.
Academic Article Maintenance therapy with certolizumab pegol for Crohn's disease.
Academic Article Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk?
Academic Article The role of biologics in ulcerative colitis.
Academic Article Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study.
Academic Article Infliximab for induction and maintenance therapy for ulcerative colitis.
Academic Article The 'tipping point' applied.
Academic Article Practical application of anti-TNF therapy for luminal Crohn's disease.
Academic Article The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
Academic Article Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center.
Academic Article Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
Academic Article Conventional treatment in inflammatory bowel disease--recent trends. Immunosuppressants and biologic agents: should they or need they be used together? How to use immunosuppressive therapy better (and safer) tomorrow?
Academic Article Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial.
Academic Article Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
Academic Article Shared experiences and best practices in the management of rheumatoid arthritis and Crohn's disease.
Academic Article Commentary: pre-operative use of anti-TNF-a agents and the risk of post-operative complications in patients with ulcerative colitis.
Academic Article Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.
Academic Article A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.
Academic Article Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegol.
Academic Article Still in pursuit.
Academic Article American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-a biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
Academic Article Comparing guidelines for the treatment of inflammatory bowel disease.
Academic Article Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.
Academic Article Briakinumab for treatment of Crohn's disease: results of a randomized trial.
Academic Article Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases.
Academic Article Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis.
Academic Article Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?
Academic Article Targeting Crohn's disease.
Academic Article Checkpoint Inhibitor-Induced Colitis.
Academic Article Early vs Late Use of Anti-TNFa Therapy in Adult Patients With Crohn Disease: A Systematic Review and Meta-Analysis.
Academic Article Immunomodulatory Agents for Treatment of Patients with Inflammatory Bowel Disease (Review safety of anti-TNF, Anti-Integrin, Anti IL-12/23, JAK Inhibition, Sphingosine 1-Phosphate Receptor Modulator, Azathioprine / 6-MP and Methotrexate).
Academic Article Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel.
Concept Tumor Necrosis Factor alpha-Induced Protein 3
Academic Article Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases.
Search Criteria
  • Tumor Necrosis Factor alpha